IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v5y2014i1d10.1038_ncomms4917.html
   My bibliography  Save this article

The FAM3 superfamily member ILEI ameliorates Alzheimer’s disease-like pathology by destabilizing the penultimate amyloid-β precursor

Author

Listed:
  • Hiroshi Hasegawa

    (Molecular Neuroscience Research Center, Shiga University of Medical Science
    Present address: Minami-Kyoto Hospital, Kyoto, Japan)

  • Lei Liu

    (Molecular Neuroscience Research Center, Shiga University of Medical Science)

  • Ikuo Tooyama

    (Molecular Neuroscience Research Center, Shiga University of Medical Science)

  • Shigeo Murayama

    (Tokyo Metropolitan Institute of Gerontology)

  • Masaki Nishimura

    (Molecular Neuroscience Research Center, Shiga University of Medical Science)

Abstract

Accumulation of amyloid-β peptide (Aβ) in the brain underlies the pathogenesis of Alzheimer’s disease (AD). Aβ is produced by β- and γ-secretase-mediated sequential proteolysis of amyloid-β precursor protein (APP). Here we identify a secretory protein named interleukin-like epithelial-mesenchymal transition inducer (ILEI, also known as FAM3 superfamily member C) as a negative regulator of Aβ production. ILEI destabilizes the β-secretase-cleaved APP carboxy-terminal fragment, the penultimate precursor of Aβ, by binding to the γ-secretase complex and interfering with its chaperone properties. Notch signalling and γ-secretase activity are not affected by ILEI. We also show neuronal expression of ILEI and its induction by transforming growth factor-β signalling. The level of secreted ILEI is markedly decreased in the brains of AD patients. Transgenic (Tg) overexpression of ILEI significantly reduces the brain Aβ burden and ameliorates the memory deficit in AD model mice. ILEI may be a plausible target for the development of disease-modifying therapies.

Suggested Citation

  • Hiroshi Hasegawa & Lei Liu & Ikuo Tooyama & Shigeo Murayama & Masaki Nishimura, 2014. "The FAM3 superfamily member ILEI ameliorates Alzheimer’s disease-like pathology by destabilizing the penultimate amyloid-β precursor," Nature Communications, Nature, vol. 5(1), pages 1-13, September.
  • Handle: RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms4917
    DOI: 10.1038/ncomms4917
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/ncomms4917
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/ncomms4917?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms4917. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.